Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Filament Health Corp (OP: FLHLF ) 0.0373 +0.0023 (+6.57%) Streaming Delayed Price Updated: 12:05 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Filament Health Corp < Previous 1 2 3 Next > Optimi Health Signs Two New Supply Agreements In Less Than a Week May 31, 2022 Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. Via Benzinga Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say May 20, 2022 Patents are the golden eggs of the booming psychedelic space. Via Benzinga Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth April 27, 2022 Just two weeks ago, Filament Health (OTCQB: FLHLF) was issued a patent by the U. S. Patent and Trademark Office to extract and standardize natural psilocybin. Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market April 22, 2022 Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. Via Benzinga Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know April 19, 2022 Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the... Via Benzinga Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin April 13, 2022 Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and... Via Benzinga Filament Health Corp. (FLHLF) Featured in Virtual Coverage of the 34th Annual Roth Conference March 11, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins February 07, 2022 This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. Via Benzinga Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants January 31, 2022 Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants. Via Benzinga Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington January 10, 2022 Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... Via Benzinga How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions November 16, 2021 Image by Mathew Schwartz from Unsplash The following post was written and/or pu... Via Benzinga Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval November 08, 2021 Detroit Decriminalizes Psychedelics Via Benzinga Exposures Product Safety The Power Play by The Market Herald Releases New Interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven Brands Inc., and Xali Gold Corp. November 03, 2021 VANCOUVER, BC / ACCESSWIRE / November 3, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven... From The Market Herald Via AccessWire Topics Cannabis Exposures Cannabis Product Safety Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial November 02, 2021 Psychedelic drug discovery company Filament Health Corp. (OTCQB: Via Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.